Results 151 to 160 of about 28,766 (212)

Challenges in Managing Brain Metastases From Merkel Cell Carcinoma in an Immunosuppressed Patient: A Case Report. [PDF]

Cureus
Rebelo F, Morais Pinheiro T, Pimentel J, Pontinha C, Gerhardt J.   +4 more
europepmc   +1 more source

Immune Checkpoint Inhibitors in Merkel Cell Carcinoma of the Skin: A 2025 Comprehensive Review. [PDF]

Cancers (Basel)
Tai P, Alqaisi O, Al-Ghabeesh S, Sijarina L, Yu E, Thachuthara AJ, Assouline A, Souied O, Hagel K, Joseph K.   +9 more
europepmc   +1 more source

Optimizing surgical margins in the treatment of eyelid Merkel cell carcinoma: a tertiary center experience and literature review. [PDF]

Front Ophthalmol (Lausanne)
Strianese D, Barbato C, Troisi M, Lanni V, Damiano V, Di Crescenzo RM, Passaro ML, D'Aponte A, Nubi R, Conson M, Cohen D, Mariniello G, Costagliola C, Iuliano A.   +13 more
europepmc   +1 more source

Case Report: Severe neutropenia induced by avelumab in a patient with Merkel cell carcinoma. [PDF]

Front Immunol
Ohta E, Yamamoto K, Fujimura H, Saito-Sasaki N, Okada E, Sawada Y.   +5 more
europepmc   +1 more source

Long-term immune checkpoint inhibition therapy for advanced stage Merkel cell carcinoma. [PDF]

JAAD Case Rep
Diiorio MR, Trepanowski N, Shah P, Shirai K.   +3 more
europepmc   +1 more source

Merkel cell carcinoma originating in the gluteal region. [PDF]

JAAD Case Rep
Fennig S, Landman Y, Brenner R, Fenig E.
europepmc   +1 more source

Distant Metastasis of Merkel Cell Carcinoma: A Descriptive Study. [PDF]

Dermatol Pract Concept
Muntaner-Virgili C, Boronat-Cucarull J, Ferreres JR, Gamissans M, Marcoval J, Fernández-Calvo D, Penín RM, Bermejo J, Huesa-Barceló L, Manzano-Mora S, Ruzafa-Martínez E, Bajen-Lázaro MT, Benítez-Segura A, Notta PC, Jiménez-Colomo L, Martín-Liberal J, Araguas-Mora P, Juárez-Lozano M, Linares-Galiana I.   +18 more
europepmc   +1 more source

Line-field Confocal Optical Coherence Tomography Features of Merkel Cell Carcinoma. [PDF]

Dermatol Pract Concept
Palmisano G, Lasudry J, Boussingault L, Del Marmol V, Peris K, Suppa M.   +5 more
europepmc   +1 more source

Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial. [PDF]

J Immunother Cancer
Brohl AS, Sondak VK, Wuthrick EJ, Kim Y, Eroglu Z, Markowitz J, Tarhini AA, Fan W, Martin J, Sneed L, Perez MC, Sarnaik A, Harrington M, Neves RI, Gonzalez RJ, Cruse CW, Zager JS, Tsai KY, Khushalani NI.   +18 more
europepmc   +1 more source